Nonalcoholic steatotic hepatitis (NASH) Market, By types(serums biomarkers, Hepatic fibrosis biomarkers, Oxidative stress biomarkers, Apoptosis biomarkers, and others), by application (Pharma, Hospitals, Academic Institutes) And Geography (North America, Europe, Asia Pacific, And Rest Of The World) Analysis, Share, Trends, Size, & Forecast From 2016 2027- COVID- 19 Updated
- Published Date: 2020-10-13
- Report ID: 1780
- Pages: 230
-
Format:
The Nonalcoholic steatotic hepatitis (NASH) market is estimated to represent a global market of USD 3,898.6 million by 2019 with growth rate of 25.2%.
Nonalcoholic steatotic hepatitis (NASH) is the most prevalent form of progressive liver disease condition. The market is categorized into serums biomarkers, Hepatic fibrosis biomarkers, Oxidative stress biomarkers, Apoptosis biomarkers, and others. Serum biomarkers segment held the largest share of the global market, accounted for more than 40% share. Benefits such as its ability to distinguish simple steatosis from NASH offers competitive advantage over other product segments. On contrary, hepatic fibrosis biomarkers is expected to grow with highest growth rate due to rising interest of companies to invest in this product.
However, poorly suited regulatory and reimbursement guidelines pose as a threat to the global market. As per the application section, pharmaceutical industry dominated the overall market. Increasing number of pharma companies involved in research activities of NASH drugs coupled with rising number of clinical studies augments the market growth. This market segment is also expected to grow with highest CAGR owing to the rising initiatives pertaining to the development of NASH drugs.
COVID-19 Impact & Recovery Analysis
The proposed report from AnalystView Market Insights suggests three possible forecast scenarios (probable, optimistic, and pessimistic) considering the COVID-19 impact. Our ongoing research analysis amplifies our framework to ensure the inclusion of underlying COVID-19 crisis impact and potential paths forward. The designed report is delivering detailed insights on COVID-19 considering the changes in consumer demand, purchasing patterns, re-routing of the supply chain, and the significant interventions of governments. The updated study provides insights, and forecast, considering the COVID-19 impact on the market.
The spectrum of NAFLD & NASH is increasingly recognized both in the developed as well as developing region due to its prevalence in diabetes, insulin resistance syndrome and in obesity. North America has a well-established healthcare industry and the rising prevalence of NAFLD and NASH are expected to show a steady growth of the market during the coming years. According to National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) estimates,nearly 20% of people with NAFLD are affected by NASH.
Additionally, growing obese population coupled with increasing diabetic patients stimulate the uptake of NASH drugs hence drives the market growth. Current trends in developed regions indicated that the prevalence of obesity will cross more than 40% of the population by 2021-2027. Meanwhile, number of patients affected with diabetes is also increasing at constant rate. These would in turn provides healthy platform for the growth of NASH drugs market during the future period.
Companies such as Allergan, Intercept, Prometheus Laboratories Inc., Gilead Sciences, Galmed Pharmaceuticals, Quest Diagnostic Incorporated, Enzo Biochem, Inc. Bio-Rad Laboratories, Inc. and others are considered to be the key players of this market.
The market size and forecast for each segment has been provided for the period 2016 to 2027, considering 2019 as the base year. The report also provides the compounded annual growth rate (% CAGR) for the forecast period 2021 to 2027 for every reported segment.
The years considered for the study are:
Historical Year 2016 to 2018
Base Year 2019
Estimated Year 2020
Projected Year 2027
The proposed reports analyse and evaluates the COVID-19 impact, and anticipated change on the future market scenario on this industry, by taking into the account the economic, political, technological, and social, parameters.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
THE NONALCOHOLIC STEATOTIC HEPATITIS (NASH) MARKE,BY TYPES
Serums biomarkers
Hepatic fibrosis biomarkers
Oxidative stress biomarkers
Apoptosis biomarkers
Others
THE NONALCOHOLIC STEATOTIC HEPATITIS (NASH) MARKET, BY APPLICATION
Pharma
Hospitals
Academic Institutes
others
THE NONALCOHOLIC STEATOTIC HEPATITIS (NASH) MARKET,BY REGION
North America
Europe
Asia Pacific
Rest of the World
TABLE OF CONTENT NONALCOHOLIC STEATOTIC HEPATITIS (NASH) MARKET OVERVIEW
Study Scope
Base Year
Assumption and Methodology
EXECUTIVE SUMMARY
Key Market Facts
Geographical Scenario
Companies in the Market
NONALCOHOLIC STEATOTIC HEPATITIS (NASH) KEY MARKET TRENDS
Market Drivers
Impact Analysis of Market Drivers
Market Restraints
Impact Analysis of Market Restraints
Market Opportunities
Market Future Trends
NONALCOHOLIC STEATOTIC HEPATITIS (NASH) INDUSTRY STUDY
Company Activity Analysis
Regulatory Framework Analysis
Value Chain Analysis
NONALCOHOLIC STEATOTIC HEPATITIS (NASH) MARKET LANDSCAPE
Market Share Analysis
Key Innovators
NONALCOHOLIC STEATOTIC HEPATITIS (NASH) MARKET BY TYPES:
Overview
Serums Biomarkers
Overview
Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 2027, (US$ Million)
Hepatic Fibrosis Biomarkers
Overview
Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 2027, (US$ Million)
Oxidative Stress Biomarkers
Overview
Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 2027, (US$ Million)
Apoptosis biomarkers
Overview
Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 2027, (US$ Million)
Others
Overview
Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 2027, (US$ Million)
NONALCOHOLIC STEATOTIC HEPATITIS (NASH) MARKET BY APPLICATION:
Overview
Pharma
Overview
Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 2027, (US$ Million)
Hospitals
Overview
Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 2027, (US$ Million)
Academic Institutes
Overview
Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 2027, (US$ Million)
Others
Overview
Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 2027, (US$ Million)
NONALCOHOLIC STEATOTIC HEPATITIS (NASH) MARKET BY GEOGRAPHY
Introduction
North America
Overview
Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 2027, (US$ Million)
S.
Overview
Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 2027, (US$ Million)
Canada
Overview
Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 2027, (US$ Million)
Europe
Overview
Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 2027, (US$ Million)
France
Overview
Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 2027, (US$ Million)
Germany
Overview
Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 2027, (US$ Million)
Rest of Europe
Overview
Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 2027, (US$ Million)
Asia Pacific (APAC)
Overview
Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 2027, (US$ Million)
China
Overview
Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 2027, (US$ Million)
India
Overview
Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 2027, (US$ Million)
Rest of APAC
Overview
Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 2027, (US$ Million)
Rest of the World
Overview
Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 2027, (US$ Million)
Latin America
Overview
Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 2027, (US$ Million)
Middle East and Africa
Overview
Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 2027, (US$ Million)
KEY VENDOR ANALYSIS
Allergan
Company Overview
SWOT Analysis
Key Developments
Intercept
Company Overview
SWOT Analysis
Key Developments
Prometheus Laboratories Inc.
Company Overview
SWOT Analysis
Key Developments
Gilead Sciences
Company Overview
SWOT Analysis
Key Developments
Galmed Pharmaceuticals
Company Overview
SWOT Analysis
Key Developments
Quest Diagnostic Incorporated
Company Overview
SWOT Analysis
Key Developments
Enzo Biochem, Inc.
Company Overview
SWOT Analysis
Key Developments
Bio-Rad Laboratories, Inc.
Company Overview
SWOT Analysis
Key Developments
360 DEGREE ANALYSTVIEW
APPENDIX
Research Methodology
Abbreviations
Disclaimer
Contact Us
SCOPE AND OBJECTIVES
The objective of this report is to describe the market trends and revenue forecasts for the NONALCOHOLIC STEATOTIC HEPATITIS (NASH) Market for the upcoming years. The report focuses on defining and describing the key influencing factors for the growth of the market. It also offers an in-depth analysis of the market size (revenue), market share, major market segments, different geographic regions, key market players, and premium industry trends.
The report tracks the major market events including product launches, technological developments, mergers & acquisitions, and the innovative business strategies opted by key market players. Along with strategically analyzing the key micro markets, the report also focuses on industry-specific drivers, restraints, opportunities and challenges in the coil coatings market. The scope of this report covers the NONALCOHOLIC STEATOTIC HEPATITIS (NASH) Market by its major segments, which include the type, end user industry, and the major geographic regions.
KEY BENEFITS OF THE REPORT:
Understanding of the strategies that are being adopted by the key players in this market to stay competitive
Extensive analysis of the key players dominating the competitive landscape of this market
In-depth analysis of the key factors are propelling the growth of the global market
Detailed analysis of the geographic region that will witness the strongest growth
Granular analysis of the current market scenario and the expected market grow
Call Us
( India toll free )
+91 835 605 0278
( US toll free )
+1 800 601 6071
Drop us an email at
sales@prudentmarkets.com
Get your pre and post sales queries resolved by our Subject matter experts.
We will assist you to customize the report to fit your research needs.
Our prime focus is to provide qualitative and accurate data.
Feel free to order a sample report before purchase.
Your personal and confidential information is safe and secured.
